Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Current Drug Targets|June 3, 2020
Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future ChallengesHubert Zatorski, Radislav NakovPharmacological Reports : PR|April 28, 2016
Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapyHubert Zatorski, Mateusz Marynowski, Jakub FichnaNaunyn-Schmiedeberg'S Archives of Pharmacology|July 31, 2019
Role of glucagon-like peptides in inflammatory bowel diseases-current knowledge and future perspectivesHubert Zatorski, Maciej Sałaga, Jakub FichnaCurrent Medicinal Chemistry|October 2, 2015
Silver and other metals in the treatment of gastrointestinal diseasesKrzysztof Siczek, Hubert Zatorski, Jakub FichnaPharmaceuticals (Basel, Switzerland)|November 27, 2025
Fluid Therapy in Acute Pancreatitis-Current Knowledge and Future PerspectivesMiłosz Caban, Hubert Zatorski, Ewa Małecka-WojcieskoFolia Medica Cracoviensia|February 12, 2016
Rhenium-coated glass beads for intracolonic administration attenuate TNBS-induced colitis in mice: Proof-of-Concept StudyKrzysztof Siczek, Hubert Zatorski, Wojciech Pawlak, et al.Postepy Higieny I Medycyny Doswiadczalnej (Online)|March 27, 2015
[Genetic factors in pathogenesis, course and treatment of inflammatory bowel diseases]Hubert Zatorski, Maciej Sałaga, Marta Zielińska, et al.World Journal of Gastroenterology|November 3, 2015
Role of environmental pollution in irritable bowel syndromeMateusz Marynowski, Aleksandra Likońska, Hubert Zatorski, et al.Journal of Neurogastroenterology and Motility|February 28, 2017
Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor AgonistsPaula Mosińska, Hubert Zatorski, Martin Storr, et al.Nutrients|October 27, 2022
Dietary Interventions in Inflammatory Bowel DiseaseMałgorzata Godala, Ewelina Gaszyńska, Hubert Zatorski, et al.Pageof 4